241 related articles for article (PubMed ID: 38582847)
1. T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle.
Lin WP; Li H; Sun ZJ
EBioMedicine; 2024 Jun; 104():105154. PubMed ID: 38749300
[TBL] [Abstract][Full Text] [Related]
2. Tertiary lymphoid structures in cancer: maturation and induction.
Chen Y; Wu Y; Yan G; Zhang G
Front Immunol; 2024; 15():1369626. PubMed ID: 38690273
[TBL] [Abstract][Full Text] [Related]
3. Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.
Engelhard VH; Rodriguez AB; Mauldin IS; Woods AN; Peske JD; Slingluff CL
J Immunol; 2018 Jan; 200(2):432-442. PubMed ID: 29311385
[TBL] [Abstract][Full Text] [Related]
4. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients.
Niu L; Chen T; Yang A; Yan X; Jin F; Zheng A; Song X
Biochim Biophys Acta Rev Cancer; 2024 Jun; 1879(5):189125. PubMed ID: 38851437
[TBL] [Abstract][Full Text] [Related]
5. Absence of sympathetic innervation hampers the generation of tertiary lymphoid structures upon acute lung inflammation.
Riffard C; Letaïef L; Azar S; Casrouge A; Brunet I; Teillaud JL; Dieu-Nosjean MC
Sci Rep; 2024 May; 14(1):11749. PubMed ID: 38782985
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW; Boumelha J; Enfield KSS; Almagro J; Cha H; Pich O; Karasaki T; Moore DA; Salgado R; Sivakumar M; Young G; Molina-Arcas M; de Carné Trécesson S; Anastasiou P; Fendler A; Au L; Shepherd STC; Martínez-Ruiz C; Puttick C; Black JRM; Watkins TBK; Kim H; Shim S; Faulkner N; Attig J; Veeriah S; Magno N; Ward S; Frankell AM; Al Bakir M; Lim EL; Hill MS; Wilson GA; Cook DE; Birkbak NJ; Behrens A; Yousaf N; Popat S; Hackshaw A; ; ; Hiley CT; Litchfield K; McGranahan N; Jamal-Hanjani M; Larkin J; Lee SH; Turajlic S; Swanton C; Downward J; Kassiotis G
Nature; 2023 Apr; 616(7957):563-573. PubMed ID: 37046094
[TBL] [Abstract][Full Text] [Related]
7. 4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment.
Sellæg K; Schwienbacher R; Kranz M; Aamodt AE; Wirsing AM; Berge G; Hadler-Olsen E; Magnussen SN
Front Oncol; 2024; 14():1343839. PubMed ID: 38812785
[TBL] [Abstract][Full Text] [Related]
8. Inducing Ectopic T Cell Clusters Using Stromal Vascular Fraction Spheroid-Based Immunotherapy to Enhance Anti-Tumor Immunity.
Lee JW; Park BC; Jang NY; Lee S; Cho YK; Sharma P; Byun SW; Jeon K; Jeon YH; Park U; Ro HJ; Park HR; Kim Y; Lee DS; Chung S; Kim YK; Cho NH
Adv Sci (Weinh); 2022 Oct; 9(28):e2203842. PubMed ID: 36058002
[TBL] [Abstract][Full Text] [Related]
9. The tumor-driven antibody-mediated immune response in cancer.
Paparoditis P; Shulman Z
Curr Opin Immunol; 2024 Jun; ():102431. PubMed ID: 38866666
[TBL] [Abstract][Full Text] [Related]
10. Targeted modulation of immune cells and tissues using engineered biomaterials.
Yousefpour P; Ni K; Irvine DJ
Nat Rev Bioeng; 2023 Feb; 1(2):107-124. PubMed ID: 37772035
[TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
N J; J T; Sl N; Gt B
Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
[TBL] [Abstract][Full Text] [Related]
12. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
13. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
14. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.
Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z
Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy.
Wang Q; Sun K; Liu R; Song Y; Lv Y; Bi P; Yang F; Li S; Zhao J; Li X; Chen D; Mei J; Yang R; Chen K; Liu D; Tang S
Clin Transl Med; 2023 Aug; 13(8):e1346. PubMed ID: 37525587
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
